Clinicians depend on evidence-based resources to make informed decisions and provide successful patient care. Learn more about the latest tools, including point-of-care tools, decision aids and clinical information resources.
A possible increased risk of skin cancer with thiazide diuretics is unlikely to change prescribing. Read more in the latest EBM Focus.
EBM Focus: Thiazide Diuretics and Skin Cancer? Don’t Get Burned by the Hype
July 10, 2019
Clinical educator Dan Ostrovsky, Associate Professor of Internal Medicine and Pediatrics at Duke University, offers teaching tips to maximize new resident understanding and lifelong learning.
Teaching Tips for Clinical Educators at the Start of the New Internship/Resident Year
June 27, 2019
A new trial adds to the evidence that MMR vaccination does not increase risk of autism, even among high-risk children.
EBM Focus: Continuing to Debunk Ties Between MMR Vaccination and Autism Spectrum Disorder
June 25, 2019
Read about the GRADE Working Group’s recently published paper in BMJ Open on decision-making via certainty of net benefit, lead author Dr. Brian Alper MD, MSPH, FAAFP, Founder of DynaMed and Vice President of Innovations and EBM Development at EBSCO Information Services.
Defining Certainty of Net Benefit: A Concept Years in the Making
June 24, 2019
A new trial adds to the evidence for a benefit of thrombolytics for stroke beyond four and a half hours.
EBM Focus: Pushing the needle — Benefit of Thrombolytics for Stroke beyond Four and a Half Hours
June 18, 2019
Find out how EHR embedded shared decision making tools can help clinicians present personalized recommendations for a particular decision, leaving more time for productive patient conversations.
How EHR Embedded Shared Decision Making Tools Increase Quality of Care
June 11, 2019
A new study evaluates the evidence behind clinical practice recommendations in cardiology guidelines. Read the EBM Focus article — concise summaries of clinical trials most likely to inform clinical practice — curated by the DynaMed® editorial team.
EBM Focus: Expert Opinion and Low-quality Evidence Still Drive Strong Recommendations in Cardiology
June 10, 2019
Dr. Martin (Marty) Mayer discusses the long-running problem of misunderstanding and misapplying the concept of “statistical significance” and the p value.
What’s so Significant About (Statistical) Significance?
May 30, 2019
A new trial shows renal protection by canagliflozin in patients with type 2 diabetes. Read the EBM Focus article — concise summaries of clinical trials most likely to inform clinical practice — curated by the DynaMed® editorial team.
EBM Focus: Canagliflozin for Renal Protection—Not the Next ACE Inhibitor
May 29, 2019
The Infectious Disease publishing group at DynaMed Plus® breaks down what physicians need to know about measles in the United States in 2019.
Measles in 2019: What Physicians Need to Know
May 23, 2019
© 2019 EBSCO Industries, Inc. All rights reserved